non-small-cell lung cancer
Conditions
Interventions
control group:chemotherapy plus placebo granules
treatment group:chemotherapy plus FZKA granules
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. confirmed advanced NSCLC (stage IIIB or IV) with histologic features of adenocarcinoma,squamous cell carcinoma or adenosquamous carcinoma; 2. Aged 18 to 80 years old; 3. Chemotherapy patients receiving chemotherapy of any platinum; 4. Performance status score of Eastern Cooperative Oncology Group (ECOG) is 0 to 2; 5. Measurable lesions in accordance with the Response Evaluation Criteria in Solid Tumors (RECIST); 6. Proper function in bone, liver, kidney, heart and lung; 7. Good patients compliance and sign the informed consent paper.
Exclusion criteria
Exclusion criteria: 1. Expected life expectancy of less than three months; 2. Diagnosed with brain metastasis that has not been in well controlled; 3. Pericardial effusion or ascites necessitating drainage; 4. Active double cancer; 5. Pregnant or breastfeeding at present.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACIT-F; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30; | — |
Countries
China
Contacts
Public ContactWanyin Wu
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed